David N. Harpp

David N. Harpp

Auto-generated profile, based on publicly available information

David N. Harpp

Department of Chemistry, McGill University, Montreal, Quebec H3A 0B8, Canada

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Biochemical Pharmacology
Verified
Journal Article
Open access
WMWalter H. Moos
Walter H. Moos
DFDouglas V. Faller
Douglas V. Faller
IGIoannis P. Glavas
Ioannis P. Glavas
DHDavid N. Harpp
David N. Harpp
NKNatalia Kamperi
Natalia Kamperi
KSKonstantina Sampani
Konstantina Sampani
Herein we trace links between biochemical pathways, pathogenesis, and metabolic diseases to set the stage for new therapeutic advances. Cellular and acellular microorganisms including bacteria and viruses are primary pathogenic drivers that cause disease. Missing from this statement are subcellular compartments, importantly mitochondria, which can be pathogenic by themselves, also serving as key metabolic disease intermediaries. The breakdown of food molecules provides chemical energy to power cellular processes, with mitochondria as powerhouses and ATP as the principal energy carrying molecule. Most animal cell ATP is produced by mitochondrial synthase; its central role in metabolism has been known for >80 years. Metabolic disorders involving many organ systems are prevalent in all age groups. Progressive pathogenic mitochondrial dysfunction is a hallmark of genetic mitochondrial diseases, the most common phenotypic expression of inherited metabolic disorders. Confluent genetic, metabolic, and mitochondrial axes surface in diabetes, heart failure, neurodegenerative disease, and even in the ongoing coronavirus pandemic.

1 August 2004 in Journal of Sulfur Chemistry
Verified
Journal Article
Closed access
EZEli Zysman-Colman
Eli Zysman-Colman
DHDavid N. Harpp
David N. Harpp
A comparison of the structural parameters of a wide variety of compounds containing the S–S bond is summarized.

1 January 1992 in Canadian Journal of Chemistry
Verified
Journal Article
Closed access
Youla S. TsantrizosYoula S. Tsantrizos
Youla S. Tsantrizos
PFPatricia L. Folkins
Patricia L. Folkins
JBJames F. Britten
James F. Britten
DHDavid N. Harpp
David N. Harpp
KOKelvin K. Ogilvie
Kelvin K. Ogilvie
In an analogous fashion to the preparation of ergosterol peroxide from singlet oxygen, the preparation of its sulfur analog was attempted via the Diels–Alder addition of diatomic sulfur to ergosterol. Two of the recently reported methods for generating and trapping diatomic sulfur were employed as well as "activated" sulfur. Although the desired target was not obtained, several interesting steroidal products were isolated including 3,5-cyclo-6,8(14),22-ergostatriene (12), ergosta-5,7,22-trien-3-thiol (13), and ergosta-4,6,8(14),22-tetraen-3-one (16). Mechanistic aspects are discussed. Keywords: diatomic sulfur, ergosterol, sulfur analog of ergosterol peroxide, ergosta-6,22-dien-5a,8a-epidisulfide-3-ol, ergosterol peroxide, 3,5-cyclo-6,8(14),22-ergostatriene, ergosta-5,7,22-trien-3-thiol, ergosta-4,6,8(14),22-tetraen-3-one.

6 April 2007 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
NENicolas Eghbali
Nicolas Eghbali
DHDavid N. Harpp
David N. Harpp

1 December 2017 in Journal of Chemical Education
Verified
Journal Article
Closed access
DHDavid N. Harpp
David N. Harpp

26 May 2003 in Tetrahedron Letters
Verified
Journal Article
Closed access
YHYihua Hou
Yihua Hou
ARAndrzej Z. Rys
Andrzej Z. Rys
IAImad A. Abu-Yousef
Imad A. Abu-Yousef
DHDavid N. Harpp
David N. Harpp